drugset / Trial / NCT00391417

Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

NCT00391417 ↗

Phase 3 Completed 431 enrolled BioSante Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of a topical estradiol gel for the treatment of hot flushes in postmenopausal women.

Timeline

Start
2003-09
Primary completion
—
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.87 g —
Subject Estradiol Other / unclassified 1.7 g —
Subject Estradiol Other / unclassified 2.6 g —

Indications

No indication recorded.